FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to a compound of formula (I): wherein n means 1 or 2, X means an oxygen atom, a sulphur atom or NH, R1 means a side group of natural α-amino acid or its homologues or isomers specified in hydrogen, methyl, propan-2-yl, propan-1-yl, 2-methyl-propan-1-yl, imidazol-4-ylmethyl, hydroxymethyl, 1-hydroxy-ethyl, carboxymethyl, 2-carboxyethyl, carbamoyl-methyl, 2-carbamoyl ethyl a, 4-aminobutan-1-yl, 3-aminopropan-1-yl, 3-guanidinopropan-1-yl, benzyl or 4-hydroxybenzyl, R2 means hydrogen or methyl, R3 means hydrogen, or R1 and R3 are coupled together by the group (CH2)3- or (CH2)4- and together with nitrogen and carbon atoms whereto attached form a five- or six-member ring, as well to their salts, solvates and salt solvates.
EFFECT: preparing compounds for treating and/or preventing the diseases, first of all thromboembolic diseases.
2 cl, 2 tbl, 24 ex
Title | Year | Author | Number |
---|---|---|---|
AMINOACYL DERIVATIVE PRODRUGS AND PREPARATIONS FOR TREATING THROMBOEMBOLIC DISEASES | 2007 |
|
RU2435768C2 |
HETEROCYCLYLAMIDOSUBSTITUTED IMIDAZOLE DERIVATIVES | 2006 |
|
RU2415851C2 |
SULPHONIC ACID SALTS OF HETEROCYCLYLAMIDE-SUBSTITUTED IMIDAZOLES | 2012 |
|
RU2606639C2 |
SUBSTITUTED ARYLSULFONAMIDES AS ANTIVIRAL AGENTS | 2007 |
|
RU2423352C2 |
SUBSTITUTED DIHYDROPYRAZOLONES FOR TREATING CARDIOVASCULAR AND HEMATOLOGIC DISEASES, USE THEREOF, DRUG AND METHOD OF TREATING AND/OR PREVENTING | 2012 |
|
RU2611012C2 |
ACYLATED NONA-DEPSIPEPTIDES AS LYSOBACTIN DERIVATIVES | 2005 |
|
RU2414477C2 |
NEW CYCLOPENTA[B]BENZOFURANYL DERIVATIVES AND APPLICATION THEREOF | 2005 |
|
RU2415847C9 |
THIENOPYRAZOLES | 2004 |
|
RU2358978C2 |
HETEROCYCLYLAMIDE-SUBSTITUTED THAIZOLES, PYRROLES AND THIOPHENES | 2006 |
|
RU2425829C2 |
DIPEPTIDE PRODRUG, ITS APPLICATION AND MEDICINE | 2013 |
|
RU2629558C2 |
Authors
Dates
2012-07-20—Published
2007-08-23—Filed